ASSOCIATION BETWEEN TYPE 2 DIABETES AND INFLAMMATION MARKERS IN PATIENTS WITH CORONARY ARTERY DISEASE

被引：0

作者：

Lighezan, Daniel ^{[1
]}

Morgovan, Adina ^{[1
]}

Ivan, Vlad ^{[1
]}

Ardelean, Melanie ^{[1
]}

Sarau, Cristian ^{[1
]}

Ioanoviciu, Sorin ^{[1
]}

Buzas, Roxana ^{[1
]}

机构：

[1] Univ Med & Pharm Victor Babes Timisoara, Dept Internal Med, Timisoara, Romania

来源：

INTERDIAB 2016: DIABETES MELLITUS AS CARDIOVASCULAR DISEASE | 2016年

关键词：

high sensitivity C reactive protein; interleukin-6; type; 2; diabetes; inflammation marker; HEART-DISEASE; INTERLEUKIN-6; CYTOKINE;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Diabetes mellitus has been recognized as an independent major cardiovascular risk factor, coronary artery disease being the result of the synergistic effects of diabetes and inflammation in promoting atherothrombosis.The aim of this study was to evaluate the association between plasma levels of high sensitivity C reactive protein (hs-CRP) and interleukin-6 (IL-6) indiabetic patients with angiographically confirmed coronary artery disease. We observed statistically significant differences between mean values of hs-CRP between group A (coronary disease with type 2 diabetes mellitus) and group B (coronary artery disease without diabetes mellitus)(p<0.001), with increased levels in group A. We also observed that group A had significantly higher levels of plasma IL-6 (p<0.001).The study showed that increased levels of high sensitivity C reactive protein and serum interleukin-6 are associated with type 2 diabetes in patients with coronary artery disease.

引用

页码：276 / 282

页数：7

共 15 条

[1] Cardiovascular Biology of Interleukin-6 [J].

Abeywardena, Mahinda Y. ;

Leifert, Wayne R. ;

Warnes, Kirsty E. ;

Varghese, Jose N. ;

Head, Richard J. .

CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (15) :1809-1821

[2]

[Anonymous], 2003, DIABETES CARE, V26, P2949

[3]

Association American Heart, 2003, MARK INFL CARD DIS A, V107, P499

[4] Coronary heart disease in patients with diabetes - Part I: Recent advances in prevention and noninvasive management [J].

Berry, Colin ;

Tardif, Jean-Claude ;

Bourassa, Martial G. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (06) :631-642

[5] Coronary heart disease in patients with diabetes - Part II: Recent advances in coronary revascularization [J].

Berry, Colin ;

Tardif, Jean-Claude ;

Bourassa, Martial G. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (06) :643-656

[6] Interleukin-6 and vascular endothelial growth factor release by renal cell carcinoma cells impedes lymphocyte-dendritic cell cross-talk [J].

Cabillic, F. ;

Bouet-Toussaint, F. ;

Toutirais, O. ;

Rioux-Leclercq, N. ;

Fergelot, P. ;

de la Pintiere, C. Thomas ;

Genetet, N. ;

Patard, J. -J. ;

Catros-Quemener, V. .

CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2006, 146 (03) :518-523

[7] The ubiquitous interleukin-6: a time for reappraisal [J].

Fisman, Enrique Z. ;

Tenenbaum, Alexander .

CARDIOVASCULAR DIABETOLOGY, 2010, 9

[8] Management of coronary artery disease: Therapeutic options in patients with diabetes [J].

Hammoud, T ;

Tanguay, JF ;

Bourassa, MG .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (02) :355-365

[9] Mechanisms of disease - Inflammation, atherosclerosis, and coronary artery disease [J].

Hansson, GK .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (16) :1685-1695

[10]

Libby P, 2006, AM J CLIN NUTR, V83, p456S

← 1 2 →